Article
Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.
PloS one - 1 Jan 2016
Suzuki-Kemuriyama Noriko, Matsuzaka Takashi, Kuba Motoko, Ohno Hiroshi, Han Song-Iee, Takeuchi Yoshinori, Isaka Masaaki, Kobayashi Kazuto, Iwasaki Hitoshi, Yatoh Shigeru, Suzuki Hiroaki, Miyajima Katsuhiro, Nakae Dai, Yahagi Naoya, Nakagawa Yoshimi, Sone Hirohito, Yamada Nobuhiro, Shimano Hitoshi
Abstract excerpt
Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of metabolic syndrome, can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver cirrhosis and cancer. Recent studies have shown the benefits of consuming n-3 polyunsaturated fatty acids (PUFAs) for the treatment of NAFLD. In the present study, we investigated and compared the effects of the major n-3...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.